MIG‐6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple‐negative breast cancer

Treatment of triple‐negative breast cancer (TNBC) remains challenging due to a lack of effective targeted therapies. Dysregulated glucose uptake and metabolism are essential for TNBC growth. Identifying the molecular drivers and mechanisms underlying the metabolic vulnerability of TNBC is key to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jiabei, Li, Chien‐Feng, Lee, Hong‐Jen, Shin, Dong‐Hui, Chern, Yi‐Jye, Pereira De Carvalho, Bruno, Chan, Chia‐Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097377/
https://www.ncbi.nlm.nih.gov/pubmed/33655623
http://dx.doi.org/10.15252/embr.202050781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097377/
https://www.ncbi.nlm.nih.gov/pubmed/33655623
http://dx.doi.org/10.15252/embr.202050781

Ejemplares similares